Hospital or health organisation · founded 1876
The University of Texas MD Anderson Cancer Center
Houston, United States · mdanderson.org
- Citations, last 5 years
- 470.2k
- Works, last 5 years
- 44.3k
- h-index
- 1,800
- Scientists listed
- 5 302
- Grants since 2016
- 2 323
Grants received
2019–2024 · research · R01
Combating Breast Cancer Brain Metastasis by Blocking the Two-Pronged Driver Kinase Function of CDK5
Dihua Yu · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2019–2021 · career development · K99
Determining the Immunological Consequences of DNA Replication Stress Response Defects in Renal Cells Carcinoma to Improve Immunotherapy Outcomes
Daniel James Mcgrail · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2019–2020 · research · R21
Analyzing Cell-Cell Fusion in Glioblastoma Growth and Progression
Joseph H Mccarty · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2019–2023 · research · R01
Statistical methods and tools for cancer risk prediction in families with germline mutations in TP53
Wenyi Wang · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2019–2022 · grant · Standard Grant
Collaborative Research: Stochastic and Dynamic Chemotherapy Planning and Dosing
Clifton Fuller · The University of Texas MD Anderson Cancer Center · funded by National Science Foundation
2019–2024 · research · R01
Elucidating and targeting subtype-specific driver in pancreatic cancer
Haoqiang Ying · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2019–2024 · research · R01
Role of SETD5 in Chromatin Regulation and Tumorigenesis
Or P. Gozani · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2019–2024 · research · R01
The molecular and immune evolution in the progression of lung neoplasia to invasive adenocarcinoma
Jianjun Zhang · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2019–2024 · research · R01
Targeting Alterations of the NOTCH1 Pathway in Head & Neck Squamous Cell Carcinoma (HNSCC)
Mitchell J. Frederick · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2019–2022 · fellowship · F31
The Role of HIF2-Induced Wnt5a in Small Intestine Regeneration after Radiation Injury
Carolina Jannet Garcia Garcia · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2019 · grant · CPRIT Scholar
Recruitment of Established Investigators
Christopher Flowers · The University of Texas MD Anderson Cancer Center · funded by Cancer Prevention and Research Institute of Texas
2019–2022 · contract · N01
Repurposing of Macrolide Antibiotic Clarithromycin for the Prevention of Lung and Breast Cancer
Powel Brown · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2019–2025 · research · R01
Development of Long non-coding RNA-directed Target Therapy for Triple-Negative Breast Cancer
Chunru Lin · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2019–2024 · program · P50
The University of Texas MD Anderson Cancer Center SPORE in Hepatocellular Carcinoma
Laura Beretta · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2019 · research · Implementation Project (Limited Competition D&I PFA)
Putting Patient Decision Support in Place for Lung Cancer Screening through Tobacco Quitlines
Robert J. Volk · The University of Texas MD Anderson Cancer Center · funded by Patient-Centered Outcomes Research Institute
2019–2022 · fellowship · F32
Mechanisms by which mutant p53 drives metastatic Triple Negative Breast Cancer
Joy Marie Mcdaniel · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2019–2022 · research · R25
Sexual and Gender Minority Cancer Curricular Advances for Research and Education (SGM Cancer CARE)
Shine Chang · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2019–2025 · research · R01
Characterizing heterochromatin dysfunction as a driving alteration in cancer
Jason Huse · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2019–2025 · research · R01
Use of Patient-Reported Outcomes in Understanding Symptomatic Adverse Events in Early-Phase Trials of Combination Treatments that Include Immune Checkpoint Inhibitors and Targeted Therapy
Goldy C George · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2019 · grant · Academic Research
Pharmacological Targeting of the IRE1/XBP1 Pathway for Triple-Negative Breast Cancer Therapy
Albert Koong · The University of Texas MD Anderson Cancer Center · funded by Cancer Prevention and Research Institute of Texas
2019 · grant · Academic Research
Immunotherapeutic Targeting of SLC45A2 for Treatment of Uveal Melanoma
Cassian Yee · The University of Texas MD Anderson Cancer Center · funded by Cancer Prevention and Research Institute of Texas
2019–2022 · fellowship · F32
Identifying the role of Ntrk1 in immunosuppression in Kras/p53 mutant lung cancer
Jessica Konen · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2019 · award
Define predictive biomarkers for ATR inhibitors
Chao Wang · The University of Texas MD Anderson Cancer Center · funded by American Cancer Society
2019–2022 · fellowship · F32
Mechanisms by which mutant p53 drives metastatic Triple Negative Breast Cancer
Joy Marie Mcdaniel · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2019–2021 · research · R21
Developing a NF-κB/GADD45b targeting strategy for glioblastoma
Krishna Pl Bhat · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2019–2020 · contract · N01
OTHER FUNCTIONS - CANCER PREVENTION AGENT DEVELOPMENT PROGRAM: EARLY PHASE CLINICAL RESEARCH
Powel Brown · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2019–2026 · research · R35
Inducible epithelial resistance: a program investigating mechanisms to protect against acute and chronic complications of pneumonia
Scott E. Evans · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2019–2024 · research · R01
Therapeutic strategies against EGFR exon 20 mutant lung cancer
John V. Heymach · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2019–2023 · award
Yoga Program for Couples Coping with Lung Cancer
Kathrin Milbury · The University of Texas MD Anderson Cancer Center · funded by American Cancer Society
2019–2021 · research · R21
Analyzing Cell-Cell Fusion in Glioblastoma Growth and Progression
Joseph H Mccarty · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2019 · grant · CPRIT Scholar
Recruitment of Established Investigators
Theresa Guise · The University of Texas MD Anderson Cancer Center · funded by Cancer Prevention and Research Institute of Texas
2019–2022 · cooperative agreement · U01
Colorectal cancer risk factors, risk prediction and blood-based biomarker by tumor consensus molecular subtype
Robert S Bresalier · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2019–2024 · research · R01
Translating Intestinal Radioprotection by EGLN Inhibition to Improve Clinical Outcomes in Unresectable Pancreatic Cancer
Cullen Mitsuo Taniguchi · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2019–2025 · grant · Standard Grant
Collaborative Research: How between-group competition impacts within-group cooperation
Steven Schapiro · The University of Texas MD Anderson Cancer Center · funded by National Science Foundation
2019 · grant · Academic Research
A Novel Therapy Targeting Prostate Cancer–Induced Aberrant Bone Formation
Sue-Hwa Lin · The University of Texas MD Anderson Cancer Center · funded by Cancer Prevention and Research Institute of Texas
2019–2024 · research · R01
Developing Novel Therapeutic Approaches Targeting Macrophages in GBM
Y. Alan Wang · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2019–2024 · research · R01
Synthetic Lethal Targeting of CREBBP/EP300 in Head and Neck Squamous Cell Carcinoma
Curtis Pickering · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2019–2025 · grant · Standard Grant
Collaborative Research: Significance of eye morphology on gaze perception
Steven Schapiro · The University of Texas MD Anderson Cancer Center · funded by National Science Foundation
2019–2025 · research · R01
Synthetic lethality based combination approaches to ARID1A mutation in ovarian cancer
Rugang Zhang · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2019–2022 · research · R01
Targeting apoptosis in high-risk AML and MDS with BCL-2 inhibitor Venetoclax and optimized 10-day Decitabine regimen
Marina Y Konopleva · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
